Wendy Lorizio

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment
    Wendy Lorizio
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, 1545 Divisadero Street, Suite 322, San Francisco, CA 94143 0320, USA
    Genome Med 3:64. 2011
  2. doi Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score
    Alan H B Wu
    Department of Laboratory Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    Breast Cancer Res Treat 133:677-83. 2012
  3. pmc Clinical and biomarker predictors of side effects from tamoxifen
    Wendy Lorizio
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Breast Cancer Res Treat 132:1107-18. 2012

Detail Information

Publications3

  1. pmc Pharmacogenetic testing affects choice of therapy among women considering tamoxifen treatment
    Wendy Lorizio
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, 1545 Divisadero Street, Suite 322, San Francisco, CA 94143 0320, USA
    Genome Med 3:64. 2011
    ..We evaluated the effect of CYP2D6 testing in clinical practice to determine whether genotype results affected choice of hormone therapy in a prospective cohort study...
  2. doi Estimation of tamoxifen metabolite concentrations in the blood of breast cancer patients through CYP2D6 genotype activity score
    Alan H B Wu
    Department of Laboratory Medicine, San Francisco General Hospital, San Francisco, CA 94110, USA
    Breast Cancer Res Treat 133:677-83. 2012
    ..If endoxifen levels are confirmed to be predictive of tamoxifen benefit, then this algorithm may be helpful to determine which women warrant endoxifen testing...
  3. pmc Clinical and biomarker predictors of side effects from tamoxifen
    Wendy Lorizio
    Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Breast Cancer Res Treat 132:1107-18. 2012
    ..The association between endoxifen levels and side effects is consistent with the data that suggest that endoxifen is the most highly active metabolite of tamoxifen...